Epidemiology and mortality of non-idiopathic pulmonary fibrosis (IPF) progressive fibrosing interstitial lung disease (PF-ILD) using the French national health insurance system (SNDS) database in France: the PROGRESS study
M. Nasser (Lyon, France), S. Larrieu (Bordeaux, France), L. Boussel (Lyon, France), S. Si-Mohamed (Lyon, France), F. Diaz (Bordeaux, France), S. Marque (Bordeaux, France), J. Massol (Bordeaux, France), D. Revel (Lyon, France), F. Thivolet-Bejui (Lyon, France), L. Chalabreysse (Lyon, France), D. Maucort-Boulch (Lyon, France), V. Cottin (Lyon, France)
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Nasser (Lyon, France), S. Larrieu (Bordeaux, France), L. Boussel (Lyon, France), S. Si-Mohamed (Lyon, France), F. Diaz (Bordeaux, France), S. Marque (Bordeaux, France), J. Massol (Bordeaux, France), D. Revel (Lyon, France), F. Thivolet-Bejui (Lyon, France), L. Chalabreysse (Lyon, France), D. Maucort-Boulch (Lyon, France), V. Cottin (Lyon, France). Epidemiology and mortality of non-idiopathic pulmonary fibrosis (IPF) progressive fibrosing interstitial lung disease (PF-ILD) using the French national health insurance system (SNDS) database in France: the PROGRESS study. 444
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: